Show simple item record

dc.contributor.authorBaker, Den_US
dc.contributor.authorHerrod, SSen_US
dc.contributor.authorAlvarez-Gonzalez, Cen_US
dc.contributor.authorGiovannoni, Gen_US
dc.contributor.authorSchmierer, Ken_US
dc.date.accessioned2017-08-29T13:15:27Z
dc.date.available2017-03-24en_US
dc.date.issued2017-08en_US
dc.date.submitted2017-04-04T10:19:16.278Z
dc.identifier.issn2168-6149en_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/25508
dc.format.extent961 - 969en_US
dc.language.isoenen_US
dc.relation.ispartofJAMA NEUROLOGYen_US
dc.titleInterpreting Lymphocyte Reconstitution Data From the Pivotal Phase 3 Trials of Alemtuzumaben_US
dc.typeArticle
dc.rights.holder(c) American Medical Association (AMA)
dc.identifier.doi10.1001/jamaneurol.2017.0676en_US
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407688300016&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue8en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume74en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record